These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1236694

  • 21. [Examination of lymphokines in patients with hemodialysis (author's transl)].
    Löcsey L, Kálmán K, Hauck M, Kakuk G.
    Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
    [Abstract] [Full Text] [Related]

  • 22. beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.
    Montali U, Pilone N, Cioni L, Ronca G.
    Int J Tissue React; 1984; 6(1):71-4. PubMed ID: 6370888
    [Abstract] [Full Text] [Related]

  • 23. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. II. Chief peptide constituents of the faction.
    Klein A, Sarnecka-Keller M, Hanicki Z.
    Clin Chim Acta; 1978 Nov 15; 90(1):7-11. PubMed ID: 719891
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS, Bastl C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P.
    J Clin Invest; 1976 Mar 15; 57(3):722-31. PubMed ID: 1249205
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Molecular weight distribution, diffusibility and comparability of middle molecular fractions prepared from normal and uremic sera by different fractionation procedures.
    Gróf J, Menyhárt J.
    Nephron; 1982 Mar 15; 30(1):60-7. PubMed ID: 7088233
    [Abstract] [Full Text] [Related]

  • 31. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC, Mikkers FE, Claessens HA, De Smet R, Van Landschoot N, Ringoir SM.
    Clin Chem; 1982 Jan 15; 28(1):45-9. PubMed ID: 7055936
    [Abstract] [Full Text] [Related]

  • 32. Ultrafiltration for middle molecules in uraemia.
    Reiger J, Quellhorst E, Lowitz HD, Kong RG, Scheler F.
    Proc Eur Dial Transplant Assoc; 1975 Jan 15; 11():158-64. PubMed ID: 812083
    [Abstract] [Full Text] [Related]

  • 33. Characterization of middle molecule compounds.
    Zimmerman L, Jörnvall H, Bergström J, Fürst P, Sjövall J.
    Artif Organs; 1981 Jan 15; 4 Suppl():33-6. PubMed ID: 7295092
    [Abstract] [Full Text] [Related]

  • 34. Inhibitor of marrow thymidine incorporation from sera of patients with uremia.
    Gutman RA, Huang AT.
    Kidney Int; 1980 Dec 15; 18(6):715-24. PubMed ID: 7206456
    [Abstract] [Full Text] [Related]

  • 35. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.
    Boumendil-Podevin EF, Podevin RA, Richet G.
    J Clin Invest; 1975 Jun 15; 55(6):1142-52. PubMed ID: 1133164
    [Abstract] [Full Text] [Related]

  • 36. Amino acid containing compounds in uremic serum-search for middle molecules by high performance liquid chromatography.
    Kaplan B, Gotfried M, Ravid M.
    Clin Nephrol; 1986 Aug 15; 26(2):66-71. PubMed ID: 3757315
    [Abstract] [Full Text] [Related]

  • 37. Erythropoietic inhibitors in uremic serum.
    Freedman MH, Grunberger T, Saunders EF.
    Clin Invest Med; 1982 Aug 15; 5(4):237-40. PubMed ID: 7160111
    [Abstract] [Full Text] [Related]

  • 38. Uremic middle molecules: analytical study of middle molecular weight fractions subpeak b4-2.
    Le Moel G, Strecker G, Cueille G, Boudet J, Man NK, Galli A, Agneray J.
    Artif Organs; 1981 Aug 15; 4 Suppl():17-21. PubMed ID: 7295087
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.
    Ringoir SM, van Landschoot N, de Smet R.
    Clin Nephrol; 1980 Mar 15; 13(3):109-12. PubMed ID: 7379359
    [Abstract] [Full Text] [Related]

  • 40. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T, Ichikawa T.
    Biochem Exp Biol; 1979 Mar 15; 15(3):229-36. PubMed ID: 122165
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.